RCS - Moolec Science SA - Moolec Achieves USDA-APHIS Regulatory Clearance

Moolec Science SaAnnouncement

06/04/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230406:nRSF4435Va&default-theme=true

RNS Number : 4435V  Moolec Science SA  06 April 2023

Moolec Science Achieves USDA-APHIS Regulatory Status Review Clearance for
Molecular Farming Product

LUXEMBOURG / ACCESSWIRE / April 5, 2023 / Moolec Science SA (NASDAQ:MLEC)
("Company" or "Moolec"), a Molecular Farming food-ingredient company,
announced today that the Animal and Plant Health Inspection Service ("APHIS")
of the U.S. Department of Agriculture ("USDA") has concluded that Moolec's GLA
safflower plants pose no greater plant pest risk than non-genetically
engineered safflower plants according to regulation found at 7 CFR part 340.
To access the Regulatory Status Review ("RSR") response from USDA-APHIS, click
here (https://pr.report/piWafISN) .

Moolec's CEO and co-founder Gastón Paladini stated, "This important milestone
reinforces our go-to-market path and validates our proposed regulatory
strategy. Also, it complements the FDA's food safety reviews and approvals
already obtained for our GLA safflower oil (GLASO)." He finished by declaring,
"The green light from USDA-APHIS bolsters the idea of the safe use of
Molecular Farming technology to improve nutritional profile for end food
products. Moolec is very excited that its innovative food ingredients are a
key part of the bioeconomy."

Martin Salinas, Chief of Technology and co-founder of Moolec, expressed, "This
will greatly increase the efficiency of our operations, including raw material
procurement, downstream crushing, and processing. We will no longer need
USDA-APHIS permits to import, move interstate or grow these plants in the
field in the United States." He concluded, "We are positive that this
achievement paves the way for our upcoming regulatory reviews in our
pipeline."

According to USDA-APHIS regulation found at 7 CFR part 340, developers may
submit a request for a RSR when they believe a genetically engineered ("GE")
plant is not subject to the regulation. APHIS reviews the GE plant and
considers whether it might pose an increased plant pest risk compared to its
non-GE comparator. If APHIS does not identify a greater pest risk relative to
the comparator, the GE plant is not subject to this regulation. Regulation 7
CFR part 340 governs the importation, interstate movement, and the
environmental release of certain organisms that have been modified or produced
by genetic engineering.

About Moolec Science SA

Moolec is a science-based food ingredient company focused on producing animal
proteins in plants through Molecular Farming, a disruptive technology in the
alternative protein landscape. Its purpose is to upgrade taste, nutrition, and
affordability of alternative protein products while building a more
sustainable and equitable food system. The Company's technological approach
aims to have the cost structure of plant-based solutions with the organoleptic
properties and functionality of animal-based ones. Moolec's technology has
been under development for more than a decade and is known for pioneering the
production of a bovine protein in a crop for the food industry. The Company's
product portfolio and pipeline leverage the agronomic efficiency of broadly
used target crops, like safflower, soybean, and pea. Moolec has a growing
international patent portfolio (23, both granted and pending) for its
Molecular Farming technology. The Company is run by a diverse team of Ph.Ds
and Food Insiders, and operates in the United States, Europe, and South
America. For more information, visit www.moolecscience.com
(https://pr.report/yVGnkMZQ) .

Forward-Looking Statements

This press release contains "forward-looking statements." Forward-looking
statements may be identified by the use of words such as "forecast," "intend,"
"seek," "target," "anticipate," "believe," "expect," "estimate," "plan,"
"outlook," and "project" and other similar expressions that predict or
indicate future events or trends or that are not statements of historical
matters. Such forward-looking statements with respect to performance,
prospects, revenues, and other aspects of the business of Moolec Science S.A.
("Moolec") are predictions, projections and other statements about future
events that are based on current expectations and assumptions and, as a
result, are subject to risks and uncertainties. Although we believe that we
have a reasonable basis for each forward-looking statement contained in this
press release, we caution you that these statements are based on a combination
of facts and factors, about which we cannot be certain. We cannot assure you
that the forward-looking statements in this press release will prove accurate.
These forward-looking statements are subject to a number of significant risks
and uncertainties that could cause actual results to differ materially from
expected results, including, among others, changes in applicable laws or
regulations, the possibility that Moolec may be adversely affected by
economic, business and/or other competitive factors, costs related to the
scaling up of Moolec's business and other risks and uncertainties, including
those included under the header "Risk Factors" in the Form F-1 Registration
Statement filed with the U.S. Securities and Exchange Commission ("SEC"), as
well as Moolec's other filings with the SEC. Should one or more of these risks
or uncertainties materialize, or should any of our assumptions prove
incorrect, actual results may vary in material respects from those projected
in these forward-looking statements. We undertake no obligation to update or
revise any forward-looking statements, whether as a result of new information,
future events or otherwise, except as may be required under applicable
securities laws. Accordingly, you should not put undue reliance on these
statements.

Contact Information

Catalina Jones

Chief of Staff & Sustainability
comms@moolecscience.com (mailto:comms@moolecscience.com)

Martín Taraciuk

Investor Relations
ir@moolecscience.com (mailto:ir@moolecscience.com)

Michael Bowen

ICR, LLC
moolecir@icrinc.com (mailto:moolecir@icrinc.com)

Related Files

Moolec Science Achieves USDA-APHIS Regulatory Status Review Clearance for
Molecular Farming Product - 2023.04.05.pdf (https://pr.report/wjsNrt1m)

SOURCE: Moolec Science

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAFIFELSEIRIIV